Structural alterations in the 5' region of the BCL2 gene in follicular lymphomas with BCL2-MBR or BCL2-MCR rearrangements
- PMID: 1906343
- DOI: 10.1002/gcc.2870030206
Structural alterations in the 5' region of the BCL2 gene in follicular lymphomas with BCL2-MBR or BCL2-MCR rearrangements
Abstract
We report a new class of molecular lesions in the 5' region of the BCL2 protooncogene when it undergoes a t(14;18) translocation-associated rearrangement in the major break cluster (MBR) or minor break cluster (MCR) regions. Among 52 tumors assayed for BCL2 rearrangements using the MBR, MCR, and 5' probes, seven (six with MBR and one with MCR translocation breaks) showed aberrant bands in unique enzyme digests of DNA hybridized with the 5' probe. The aberrant bands in four tumors were in HindIII digests, in two they were in EcoRI digests, while the aberrant band in one was in a BamHI digest. The two EcoRI bands and two of the four HindIII bands were of identical sizes. Germline polymorphisms as the source of these bands was ruled out by appropriate control experiments. These results suggest that the bands were derived from point mutations or small deletions in the 5' region of BCL2. The significance of this alteration to BCL2 function in translocation-carrying tumors remains to be determined.
Similar articles
-
Concurrent activation of MYC and BCL2 in B cell non-Hodgkin lymphoma cell lines by translocation of both oncogenes to the same immunoglobulin heavy chain locus.Leukemia. 1996 Jul;10(7):1198-208. Leukemia. 1996. PMID: 8684002
-
Detection of rearrangements of the BCL2 major breakpoint region in follicular lymphomas. Correlation of polymerase chain reaction results with Southern blot analysis.Diagn Mol Pathol. 1992 Mar;1(1):31-5. doi: 10.1097/00019606-199203000-00005. Diagn Mol Pathol. 1992. PMID: 1342952
-
BCL2 complex rearrangement in follicular lymphoma: translocation mbr/JH and deletion in the vcr region of the same BCL2 allele.Oncogene. 1993 Nov;8(11):3073-80. Oncogene. 1993. PMID: 8414508
-
t(2;18) and t(18;22) variant chromosomal translocations and bcl-2 gene rearrangements in human malignant lymphomas.Nouv Rev Fr Hematol (1978). 1990;32(6):401-3. Nouv Rev Fr Hematol (1978). 1990. PMID: 2129304 Review.
-
Detection of minimal residual disease in patients with lymphomas using the polymerase chain reaction.Important Adv Oncol. 1994:117-29. Important Adv Oncol. 1994. PMID: 8206485 Review. No abstract available.
Cited by
-
Heterogeneous breakpoints on the immunoglobulin genes are involved in fusion with the 5' region of BCL2 in B-cell tumors.Jpn J Cancer Res. 2001 Sep;92(9):933-40. doi: 10.1111/j.1349-7006.2001.tb01183.x. Jpn J Cancer Res. 2001. PMID: 11572760 Free PMC article.
-
The Minimal Residual Disease in Non-Hodgkin's Lymphomas: From the Laboratory to the Clinical Practice.Front Oncol. 2019 Jun 26;9:528. doi: 10.3389/fonc.2019.00528. eCollection 2019. Front Oncol. 2019. PMID: 31293969 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials